You are here

Pfizer

Pfizer’s latest copycat could put the squeeze on Roche — again

Endpoints

Fri, 01/26/18 - 10:57 am

Pfizer's EpiPen woes creep into Canada

Biopharma Dive

Fri, 01/26/18 - 09:04 am

Johnson & Johnson drops out of the race for Pfizer consumer unit, paving the way for GSK, Reckitt

Fierce Pharma

Thu, 01/25/18 - 05:29 pm

consumer health

Reckitt Benckiser

Bristol-Myers calls on real-world evidence to unseat warfarin

Biopharma Dive

Wed, 01/24/18 - 08:15 pm

Bristol-Myers Squibb

J&J’s move to cut Remicade price cost some big bucks, but guarded against Pfizer’s copycat

Endpoints

Tue, 01/23/18 - 09:00 pm

Pfizer (PFE) Set to Announce Earnings on Monday

True Blue Tribune, FL

Mon, 01/22/18 - 05:43 pm

GSK, Pfizer lead in new global Twitter pharma influencer ranking

Fierce Pharma

Mon, 01/22/18 - 11:01 am

Whom Will Pfizer Buy in 2018?

Motley Fool

Mon, 01/22/18 - 09:42 am

Bristol-Myers Squibb

5 Highest-Growth Drugs of 2018 -- and Who Will Get Rich from Them

Motley Fool

Sun, 01/21/18 - 10:53 am

Bristol-Myers Squibb

Beefing up its CAR-T pipeline, Gilead teams up with Pfizer on a lymphoma combo

Endpoints

Thu, 01/18/18 - 10:06 am

Gilead Sciences

large B-cell lymphoma

With Pfizer in hot pursuit, J&J loses a critical patent fight as it scrambles for a new prostate cancer drug OK

Endpoints

Thu, 01/18/18 - 10:00 am

prostate cancer

Pay-raise rant gone bad at Pfizer underscores worker angst

Oregon Live

Tue, 01/16/18 - 09:59 am

After 5 years, Eliquis' growth ceiling is nowhere in sight: Bristol-Myers CEO

Fierce Pharma

Thu, 01/11/18 - 09:48 am

Bristol-Myers Squibb

Giovanni Caforio

JPM18: GSK's Walmsley weighs in on Pfizer, gender diversity

Biopharma Dive

Wed, 01/10/18 - 06:53 pm

gender diversity

The 1 Word That Explains Why Pfizer's Future Looks Brighter Than Its Past

Motley Fool

Tue, 01/9/18 - 10:17 am

Pfizer is axing its neurosciences division, laying off 300 and discarding new drugs

Endpoints

Sun, 01/7/18 - 12:50 pm

In surprise move, Pfizer hands back IDO1 inhibitor

Biopharma Dive

Sat, 01/6/18 - 12:29 pm

iTeos Therapeutics

Pfizer, Novartis and more post price hikes on dozens of drugs, but AbbVie’s is worth the most

Fierce Pharma

Thu, 01/4/18 - 10:27 pm

Pfizer lines up an $830M alliance with Arvinas on protein degradation

Endpoints

Thu, 01/4/18 - 11:23 am

targeted protein degradation

drug development

Pfizer defends kidney-cancer position with Bavencio 'breakthrough'

Fierce Pharma

Wed, 01/3/18 - 10:58 am

Pages